Envisagenics Inc. (New York, N.Y.) raised $2.4 million in a seed round. Third Kind Venture Capital, Cosine LLC, Dolby Family Ventures, Dynamk Capital, NY Empire State Development, and SV Angel participated. In October, the artificial...

On April 13, the companies each received an undisclosed award from the Thiel Foundation’s Breakout Labs program. SciBac is developing therapeutics to treat antibiotic-resistant diseases using the microbiome. Gel4Med is developing an antimicrobial tissue-scaffolding matrix....

The Thiel Foundation 's Breakout Labs said it is providing funding to Azitra Inc. (Farmington, Conn.), a newco focused on using the skin microbiome to treat eczema and other skin diseases. The funds will support...

The companies each received a $350,000 award from the Thiel Foundation’s Breakout Labs program. Cortexyme is conducting preclinical testing for drug candidates against an undisclosed pathogen "tied to neurodegeneration" to treat Alzheimer’s disease and other...

Biotech IP commercialization firm NetScientific will purchase a convertible note for up to $250,000 in medical technology companies that receive awards from the Thiel Foundation's Breakout Labs program. The Breakout Labs program awards up to...

Breaking out NetScientific plc (LSE:NSCI) hopes a deal with The Thiel Foundation 's Breakout Labs will expand the biotech IP commercialization firm's reach in terms of geography and stage of development. The partnership is designed...

Conventional wisdom says VCs don't fund research-stage companies, but the numbers - and investors who play in the space - tell a different story. Since the financial meltdown, companies with a lead program in discovery or preclinical...

CytoVale received a $350,000 award from the Thiel Foundation's Breakout Labs program. The company is using its microfluidics technology to measure over 10 biophysical cell markers at rates above 2,000 cells/second to detect disease. CytoVale...

Pareto received a $350,000 award from the Thiel Foundation's Breakout Labs program. The company's platform uses polyketide pathways to create molecules with near-term applications in cosmetics, flavors and fragrances, which are derived from either limited...

Mithril Capital Management , San Francisco, Calif.   Business: Finance   Date announced: 10/18/13   Mithril Capital Management closed its first fund in March at $537.7 million. LPs include families and sovereign wealth funds. Mithril invests...